DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 10,490,000 shares, a growth of 5.9% from the March 15th total of 9,910,000 shares. Currently, 12.1% of the shares of the stock are short sold. Based on an average daily volume of 1,600,000 shares, the short-interest ratio is currently 6.6 days.

Analyst Ratings Changes

DCGO has been the subject of several research analyst reports. Canaccord Genuity Group dropped their target price on shares of DocGo from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, April 11th. Needham & Company LLC cut their target price on shares of DocGo from $14.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, February 29th. BTIG Research lowered their price target on DocGo from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. Stifel Nicolaus dropped their price target on DocGo from $11.00 to $8.00 and set a "buy" rating for the company in a research note on Wednesday, April 10th. Finally, Cantor Fitzgerald reduced their price objective on DocGo from $13.00 to $11.00 and set an "overweight" rating on the stock in a research report on Thursday, February 29th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $10.83.

Insider Activity

In other DocGo news, Director Michael J. Burdiek acquired 10,000 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were bought at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the completion of the transaction, the director now owns 571,595 shares of the company's stock, valued at approximately $2,063,457.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 13.78% of the company's stock.

Hedge Funds Weigh In On DocGo

Several hedge funds have recently made changes to their positions in DCGO. AJOVista LLC bought a new stake in DocGo in the fourth quarter valued at $25,000. Federated Hermes Inc. purchased a new stake in shares of DocGo in the 3rd quarter worth about $29,000. Royal Bank of Canada boosted its stake in shares of DocGo by 226.3% during the 1st quarter. Royal Bank of Canada now owns 3,263 shares of the company's stock valued at $30,000 after purchasing an additional 2,263 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of DocGo by 145.6% during the third quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company's stock valued at $31,000 after buying an additional 3,502 shares during the period. Finally, Wells Fargo & Company MN increased its position in shares of DocGo by 320.1% during the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company's stock valued at $44,000 after buying an additional 4,718 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Trading Up 0.3 %

Shares of DCGO stock traded up $0.01 during mid-day trading on Tuesday, reaching $3.26. The stock had a trading volume of 610,235 shares, compared to its average volume of 1,579,584. The firm has a market capitalization of $339.59 million, a PE ratio of 46.86, a price-to-earnings-growth ratio of 0.33 and a beta of 0.91. The stock's 50-day moving average price is $3.73 and its two-hundred day moving average price is $4.68. DocGo has a 52-week low of $2.78 and a 52-week high of $10.82.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.07). The business had revenue of $199.25 million during the quarter, compared to the consensus estimate of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, equities research analysts forecast that DocGo will post 0.35 earnings per share for the current year.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.